Yiling Pharmaceutical: Application for clinical trials of innovative drug "G201-Na Capsules" accepted.

Yiling Pharmaceutical announced that on April 29, 2025, the company received the "Acceptance Notice" issued by the National Medical Products Administration. G201-Na Capsules is a Class 1 chemical new drug independently developed by the company, belonging to small molecule gonadotropin-releasing hormone receptor antagonists, used for assisting reproduction, controlling controlled ovarian hyperstimulation treatment patients, and preventing premature ovulation.